| scholarly article | Q13442814 |
| P50 | author | Catalina Betancur | Q30668370 |
| P2093 | author name string | W Rostène | |
| D Gully | |||
| D Pélaprat | |||
| G Vela | |||
| M Canton | |||
| P2860 | cites work | Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor | Q24314254 |
| Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor | Q24563882 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami | Q28245181 | ||
| The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences | Q28280818 | ||
| Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution | Q28283120 | ||
| Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain | Q28287754 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence | Q34245314 | ||
| Direct demonstration of three different states of the pancreatic cholecystokinin receptor | Q35079231 | ||
| Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain | Q37396060 | ||
| The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. | Q38306911 | ||
| Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography | Q38310093 | ||
| Pharmacology and biochemistry of neurotensin receptors | Q39461819 | ||
| The brain of the guinea pig in stereotaxic coordinates | Q41205564 | ||
| [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor | Q41348599 | ||
| The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors | Q41492785 | ||
| In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes | Q41496282 | ||
| Structure and functional expression of the cloned rat neurotensin receptor | Q41733457 | ||
| The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes | Q41899918 | ||
| Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors | Q42205984 | ||
| Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. | Q42497176 | ||
| Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin | Q42517380 | ||
| Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors | Q44463966 | ||
| Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study | Q44923249 | ||
| Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals | Q45192865 | ||
| Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. | Q46875721 | ||
| Different subcellular localization of neurotensin-receptor and neurotensin-acceptor sites in the rat brain dopaminergic system | Q48097373 | ||
| Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists | Q48149264 | ||
| SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures | Q48158232 | ||
| Neurotensin in the human brain | Q48222321 | ||
| Characterization and autoradiographic distribution of neurotensin binding sites in the human brain | Q48428279 | ||
| Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. | Q48643881 | ||
| Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors | Q48668858 | ||
| Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem | Q48670799 | ||
| Characterization and visualization of neurotensin binding to receptor sites in human brain | Q48682917 | ||
| The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system | Q48959642 | ||
| Neurotensin receptors are located on dopamine-containing neurones in rat midbrain | Q49134437 | ||
| Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis | Q49158261 | ||
| The Neurobiology of Neurotensin. Proceedings of 2nd International Conference on Neurotensin. Palm Beach, Florida, July 8, 1991 | Q67888293 | ||
| Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro | Q69375836 | ||
| Heterogeneity of [3H]neurotensin bindings: studies with dynorphin, L-156,903 and levocabastine | Q69929632 | ||
| Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites | Q70434547 | ||
| Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor | Q72420075 | ||
| Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways | Q84305745 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1450-1458 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain | |
| P478 | volume | 273 |
| Q48407590 | The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. | cites work | P2860 |
Search more.